Camelot Portfolios’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,500
Closed -$7.5K 403
2025
Q4
$7.5K Buy
+1,500
New +$7.81K ﹤0.01% 450
2024
Q3
Sell
-1,500
Closed -$6.46K 394
2024
Q2
$6.46K Buy
+1,500
New +$7.19K ﹤0.01% 449
2020
Q1
Sell
-19,338
Closed -$408K 234
2019
Q4
$408K Sell
19,338
-1,688
-8% -$34.2K 0.17% 137
2019
Q3
$411K Sell
21,026
-3,684
-15% -$67.7K 0.19% 125
2019
Q2
$431K Sell
24,710
-1,470
-6% -$26.5K 0.18% 141
2019
Q1
$485K Sell
26,180
-8,143
-24% -$145K 0.2% 133
2018
Q4
$552K Buy
34,323
+1,932
+6% +$30.6K 0.26% 111
2018
Q3
$483K Sell
32,391
-14,568
-31% -$212K 0.22% 114
2018
Q2
$659K Sell
46,959
-5,611
-11% -$74.3K 0.28% 99
2018
Q1
$684K Buy
+52,570
New +$673K 0.32% 86

Other funds holding MPT

Camelot Portfolios's MPT Position: Q1 2026 in Review

Camelot Portfolios sold out of Medical Properties Trust (MPT) in Q1 2026, closing a stake of 1,500 shares — an estimated $7.5K sold.

Camelot Portfolios first reported a position in MPT in Q1 2018 and held it in 10 quarters. The position peaked at $684K in Q1 2018. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Camelot Portfolios reported no remaining Medical Properties Trust position as of Q1 2026 after selling out during the quarter.
  • Camelot Portfolios sold 1,500 Medical Properties Trust shares in Q1 2026, an estimated $7.5K.
  • Camelot Portfolios first reported a position in Medical Properties Trust in Q1 2018 and held it in 10 quarters.
  • Camelot Portfolios's Medical Properties Trust position peaked at $684K in Q1 2018.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.